View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
July 29, 2021updated 04 Aug 2021 6:43am

FDA approves Medtronic’s AI algorithms for cardiac monitoring

The AI algorithms lower AF and asystole false alerts provided by the LINQ II insertable cardiac monitor.

The US Food and Drug Administration (FDA) has granted clearance to Medtronic’s two artificial intelligence (AI) algorithms for use with the LINQ II insertable cardiac monitor (ICM).

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

The AccuRhythm AI algorithms use AI to enhance the precision and accuracy of heart rhythm event data captured using LINQ II. With better data, doctors will be able to improve the diagnoses and treatments of abnormal heart rhythms.

The Cloud-based AccuRhythm AI algorithms will improve the precise heart rhythm alert delivery of the small, wireless LINQ II ICM device.

Medtronic noted that the AI algorithms tackle the two most common ICM false alerts, atrial fibrillation (AF) and asystole.

AF is an irregular or quick rhythm in the upper heart chambers, while asystole is a lengthy pause between heartbeats.

Leveraging a varied and debiased database of over one million electrocardiogram heart rhythm episodes, the company developed the AccuRhythm AI platform and preliminary algorithms.

Medtronic cardiovascular diagnostics and services business chief medical officer Rob Kowal said: “Applying AccuRhythm AI to LINQ II data is a significant ICM innovation, enabling us to reduce clinical inefficiencies resulting from false alerts, and help physicians better identify and focus on the actionable data they need to treat their patients.”

In validation studies, the AccuRhythm AI AF algorithm lowered LINQ II ICM’s false alerts of AF by 74.1% and maintained 99.3% of correct alerts.

Furthermore, the Pause algorithm decreased LINQ II false pause alerts by 97.4% and maintained 100% of the right alerts.

Medtronic noted that the AccuRhythm AI algorithms will be launched on the CareLink Network this year and can be utilised by all implanted LINQ II devices in the US.

The development comes after Medtronic introduced its CE marked Prevail drug-coated balloon (DCB) catheter in Europe for the treatment of coronary artery disease (CAD) patients.

Related Companies

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network